Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Aug 26, 2014

30071_dirs_2014-08-26_6525a9f2-d251-4a44-9c20-08c9ec99a2a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-08-22

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-22 ResMed Common Stock M 2000 $20.80 Acquired 68524.015 Direct
2014-08-22 ResMed Common Stock S 2000 $51.858 Disposed 66524.015 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-22 ResMed Common Stock Options $20.80 M 2000 Disposed 2015-02-26 ResMed Common Stock (2000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $51.84 to $51.86. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.